Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection

Meng, GQ; Wang, JS; Wang, YN; Wei, N; Wang, Z

Wang, Z (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Hematol, Beijing 100050, Peoples R China.

INTERNATIONAL IMMUNOPHARMACOLOGY, 2021; 96 ():

Abstract

Patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) have a poor prognosis. This study investigated the efficacy o......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索